Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase I Clinical Studies, Single and Multiple-Dose Safety and Pharmaco-261025025
University of Michigan (INC)
Search grants from University of Michigan (INC)
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Identifying risk profiles for anterior cruciate ligament injury among female athl
Polyunsaturated Fats and the Risk of Pca
Functional Forces in Normal & Abnormal Fingers
Behavioral Evaluation of A Primate Toy
Functional Domains on the Acetylcholine Receptor
Recently added grants:
Characterizing the broad antibody response to HIV superinfection
Accelerating discovery of neutralizing paratopes with Functional Antibody Screening Technology
The 'Disaggregase' Mechanism of Holotoxin Disassembly by Protein Disulfide Isomerase
Novel mechanisms of age-enhanced vasculopathy after heart transplantation
Macrophages and Resistance to Mycobacterium Tuberculosis Infection in Humans
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA025025-002
Application #
6828861
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2003
Total Cost
Indirect Cost
Institution
Name
University of Michigan (INC)
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2003
N01 CA
Phase I Clinical Studies, Single and Multiple-Dose Safety and Pharmaco-261025025
/ University of Michigan (INC)
NIH 2002
N01 CA
Phase I Clinical Studies, Single and Multiple-Dose Safety and Pharmaco-261025025
/ University of Michigan (INC)
Comments
Be the first to comment on this grant